Prescription drug misuse among young adults is increasingly viewed as a public health concern, yet most research has focused on student populations and excluded high-risk groups. Furthermore, research on populations who report recent prescription drug misuse is limited. This study examined patterns of prescription drug misuse among high-risk young adults in Los Angeles (LA) and New York (NY), which represent different local markets for illicit and prescription drugs.
Design and Methods
Between 2009 and 2011, 596 young adults (16 to 25 years old) who had misused prescription drugs within the past 90 days were interviewed in Los Angeles and New York. Sampling was stratified to enroll three groups of high-risk young adults: injection drug users (IDUs); homeless persons; and polydrug users.
Results
In both sites, lifetime history of receiving a prescription for an opioid, tranquilizer, or stimulant was high and commonly preceded misuse. Moreover, initiation of opioids occurred before heroin and initiation of prescription stimulants happened prior to illicit stimulants. NY participants more frequently misused oxycodone, heroin, and cocaine, and LA participants more frequently misused codeine, marijuana, and methamphetamine. Combining prescription and illicit drugs during drug using events was commonly reported in both sites. Opioids and tranquilizers were used as substitutes for other drugs, e.g., heroin, when these drugs were not available.
Conclusion
Patterns of drug use among high-risk young adults in Los Angeles and New York appear to be linked to differences in local markets in each city for illicit drugs and diverted prescription drugs.
JohnstonLD, O'MalleyPM, BachmanJG, SchulenbergJE.Monitoring the future national results on adolescent drug use: Overview of key findings, 2010. Institute for Social Research, The University of Michigan, Ann Arbor, USA. Available from: http://monitoringthefuture.org/pubs/monographs/mtf-overview2010.pdf
2.
Substance Abuse and Mental Health Services Administration. Results from the 2009National Survey on Drug Use and Health: Volume I. Summary of National Findings. Office of Applied Studies. 2010; NSDUH Series H-38A, HHS Publication No. SMA 10-4856.Rockville, MD, USA. Available from: http://www.samhsa.gov/data/NSDUH/2k9NSDUH/2k9Results.htm
3.
BenotshEG, KoesterS, LuckmanD, . Non-medical use of prescription drugs and sexual risk behavior in young adults. Addict Behav2011;36:152–5.
4.
QuinteroG.Rx for a party: a qualitative analysis of recreational pharmaceutical use in a collegiate setting. J Am Coll Health2009; 58:64–70.
5.
LankenauSE, TetiM, SilvaK, BloomJJ, HarocoposA., TreeseM.Initiation into prescription opioid misuse amongst young injection drug users. Int J Drug Policy2012;23:37–44.
6.
ArriaAM, CalderinaKM, O'GradyKE, . Drug exposure opportunities and use patterns among college students: results from a longitudinal cohort study. Subst Abus2008; 29:19–38.
7.
FordJA, ArrastiaMC.Pill-poppers and dopers: a comparison of nonmedical prescription drug use and illicit/drug use among college student. Addict Behav2008; 33:934–41.
8.
TeterCJ, FaloneAE, CranfordJA, BoydCJ, McCabeSE.Nonmedical use of prescription stimulants and depressed mood among college students: frequency and routes of administration. J Subst Abuse Treat2010;38:292–8.
9.
McCabeSE, CranfordJA, BoydCJ.The relationship between past-year drinking behaviors and nonmedical use of prescription drugs: prevalence of co-occurrence in a national sample. Drug Alcohol Depend.2006;84:281–8.
10.
WuLT, WoodyGE, YangC, BlazerDG.Subtypes of nonmedical opioid users: results from the national epidemiologic survey on alcohol and related conditions. Drug Alcohol Depend2010; 112:69–80.
11.
DaniulaityteR, FalckRS, WangJ, CarlsonRG.Illicit use of pharmaceutical opioids among young polydrug users in Ohio. Addict Behav2009;34:649–53.
12.
KurtzSP, InciardiJA, SurrattHL, CottlerL.Prescription drug abuse among ecstasy users in Miami. J Addict Dis2005;24:1–16.
13.
KellyBC, ParsonsJT.Prescription drug misuse among club drug-using young adults. Am J Drug Alcohol Abuse2007;33:875–84.
14.
LankenauSE, SandersB, BloomJJ, . Prevalence and Patterns of Prescription Drug Misuse among Young Ketamine Injectors. J Drug Issues2007;37:717–36.
HernandezSH, NelsonLS.Prescription drug abuse: insight into the epidemic. Clin Pharmacol Ther2010;88:307–17.
19.
WattersJ, BiernackiP.Targeted sampling: Options for the study of hidden populations. Soc Problems1989;36:416–30.
20.
BiernackiP, WaldorfD.Snowball sampling: Problems and techniques of chain referral sampling. Soc Meth Res1981;10:141–63.
21.
BenjaminiY, HochbergY.Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc Series B1995;57:289–300.
22.
BrownBW, RussellK.Methods correcting for multiple testing: operating characteristics. Statist Med1997;16:2511–28.
23.
MillerRL.The Encyclopedia of Addictive Drugs. 2002, Greenwood Press, Westport, CT, USA.
24.
CiccaroneD, UnickGJ, KrausA.Impact of South American heroin on the US heroin market 1993-2004. Int J Drug Policy2009;20:392–401.
25.
AndradeX, SifaneckSJ, NeaigusA.Dope sniffers In New York City: An ethnography of heroin markets and patterns of use. J Drug Issues1999;29:271–98.
26.
National Drug Intelligence Center. California Central District Drug Threat Assessment.2001May. NDIC publication; document ID: 2001-S0387CCA-001. Available from: http://www.justice.gov/ndic/pubs0/668/heroin.htm
27.
FirestoneM, FischerB.A qualitative exploration of prescription opioid injection among street-based drug users in Toronto: behaviors, preferences and drug availability. Harm Reduct J2008;5:30–40.
28.
RoyE, ArrudaN, BourgoisP.The growing popularity of prescription opioid injection in downtown Montreal: New challenges for harm reduction. Subst Use Misuse2011;46:1142–50.
29.
DavisWR, JohnsonBD.Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug Alcohol Depend2008;92:267–76.
30.
BaborTF, CaulkinsJP, EdwardsG, . Drug Policy and the Public Good. 2010, Oxford University Press, New York, NY, USA.
31.
KerrT, FairbairnN, TyndallM, MarshD, LiK, MontanerJ, . Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend2007;87:39–45.
32.
WunschMJ, NakamotoK, BehonickG, MasselloW.Opioid deaths in rural Virginia: a description of the high prevalence of accidental fatalities involving prescribed medications. Am J Addict2009;18:5–14.
33.
FortunaRJ, RobbinsBW, CaiolaE, . Prescribing of controlled medications to adolescents and young adults in the United States. Pediatrics2010;126:1108–16.
34.
FaraoneSV, WilensTE.Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion. J Clin Psychiatry2007;68:e28.
35.
VolkowND, McLellanTA, CottoJH, . Characteristics of opioid prescriptions in 2009. JAMA2011;3051299–301.
DaniulaityteRD, CarlsonRG, KenneD.Initiation to pharmaceutical opioids and patterns of misuse: Preliminary qualitative findings obtained by the Ohio Substance Abuse Monitoring Network. J Drug Issues2006;36:787–808.
38.
GrauLE, DasguptaN, HarveyAP, . Illicit use of opioids: Is OxyContin a “gateway drug”?Am J Addict2007;16:166–73.
